Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00805415
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 2
Start date March 2003
Completion date February 2004

See also
  Status Clinical Trial Phase
Completed NCT00567164 - Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ Phase 3
Active, not recruiting NCT02451826 - A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women Phase 1/Phase 2
Completed NCT00915915 - Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD) Phase 2
Completed NCT03077555 - Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception Phase 4
Recruiting NCT02571543 - Can Ibuprofen Delay Ovulation in Natural Cycle-IVF? Phase 2
Completed NCT01031355 - Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium Phase 1
Terminated NCT00729404 - Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene Phase 2